Neetu Chandra Sharma

tvtn

neetu.chandra@aajtak.com

Neetu Chandra Sharma is a Senior Editor at Business Today, where she leads the magazine’s coverage of healthcare and pharmaceuticals. With over two decades of experience in top Indian newsrooms—including Mint, Hindustan Times, the India Today Group, and Zee Media—she has consistently reported on the intersection of public health policy, corporate healthcare, and the pharmaceutical industry. Her journalism spans policy deep dives, industry trends, regulatory shifts, and corporate strategy across India’s thriving hea...

The anti-diabetic segment grew 14.5% in May and continued to gain share in the domestic market.

How obesity and diabetes drugs are driving India’s pharma market growth

by Neetu Chandra Sharma |Jun 17, 2026

Obesity, diabetes and cardiac therapies are driving prescriptions and helping the domestic drug market clock six straight months of double-digit growth

According to Dr Mathur, a heart attack occurs when blood flow in a coronary artery supplying the heart muscle is blocked, usually by clot formation over an underlying cholesterol blockage.

How to read the signs of a heart attack and why ignoring heart discomfort is not a good idea

by Neetu Chandra Sharma |Jun 17, 2026

Heart attacks do not always begin with severe chest pain. Here's all you need to know about the symptoms doctors say should never be ignored.

Prescription Mandatory For Many Cough Syrups? Government Tightens Drug Safety Rules

by Aabha Bakaya |Jun 17, 2026

The government has tightened regulations on syrup-based medicines by removing key exemptions under Schedule K of the Drugs Rules. Under the new framework, cough syrups containing ingredients listed un...

The government's action is aimed at the exemption framework, not at the legal classification of individual products.

BT Explainer: Why the government has ended a key exemption for cough syrups

by Neetu Chandra Sharma |Jun 16, 2026

The amendment stops cough syrups from being sold under a decades-old exemption in small villages, placing them more firmly within the licensed pharmacy system where prescription requirements already a...

Why balancing sustainability investments with affordability remains a challenge for large hospital chains

by Neetu Chandra Sharma |Jun 16, 2026

Large hospital chains are investing in energy efficiency, wastewater recycling, green buildings, and digital monitoring systems to reduce resource consumption and operating costs. Yet, balancing susta...

Govt Tightens Cough Syrup Rules, Prescription Needed For More Formulations

by Aabha Bakaya |Jun 16, 2026

The government has tightened regulations governing the sale of cough syrups by withdrawing a key exemption under Schedule K of the Drugs Rules. The move means that more cough syrup formulations may no...

How JSW Energy is building round the-clock renewable power solutions

by Neetu Chandra Sharma |Jun 15, 2026

JSW Energy is pairing green expansion with storage, hydrogen, and thermal capacity to deliver reliable, round‑the‑clock power.

Even though fierce generic competition has driven down the cost of therapy, a monthly regimen of semaglutide still commands several thousand rupees.

Waistlines expand but drug stocks pile up: Is India's weight-loss boom fading?

by Neetu Chandra Sharma |Jun 12, 2026

India has one of the world's largest populations living with obesity and related disorders. Yet months after generic semaglutide entered the market, inventories are building up across the pharmaceutic...

For Dabur, ESG isn’t a standalone programme, it’s a long-term operation strategy

by Neetu Chandra Sharma |Jun 11, 2026

Biodiversity-linked cultivation and water-positive targets are the key to Dabur's sustainability strategy.

Government Clears Price Hike for Key Chemotherapy Drugs Amid Supply Concerns

by Sakshi Batra |Jun 11, 2026

India’s government has cleared a price revision for key chemotherapy drugs amid reported shortages of cisplatin and carboplatin across hospitals. According to Business Today’s Neetu Chandra Sharma, do...